MEET OUR TEAM
Our team is your team. We believe that relationships still matter. Our team works closely with our users to ensure a personalized experience. When your mission is to be better, faster and smarter, you need the best people driving your vision forward. You need Global Regenerative Finance.
Our multi-disciplinary team draw from their diverse backgrounds and extensive deal experience to ensure transactions are sourced, evaluated and executed in an effective and thorough manner. We are committed to offering our investors a professional and personalised service.
We have created a hands-on model where person-to-person interaction is supported and central to what we do. Our team works closely with our users to ensure a personalized experience.
Founder and CEO
Mr. Beimel received a BS in Finance from St. Vincent College in Latrobe, PA. His first job out of college was as a registered stockbroker from 1987-1998. He later changed fields and became a financial consultant from 1998-2002 as the president & CEO of Mission Bay Consulting. In 2007, Mr. Beimel started the Balkan Group and worked in international business development on behalf of a number of other firms. Around 2011-2012, Mr. Beimel was first introduced to several different kinds of innovative regenerative and stem cell therapies and became so impressed that he wanted to become a part of it; he founded Global OrthoBiologic Inc. in 2013 in order to help market and distribute these products and therapies around the world.
Mihail Blagoev was born and raised in Bulgaria.From an early age he had a clear vision of what he wanted to accomplish and felt compelled to work tirelessly to make that happen. While studying Business Administration and Finance, he began helping in the family business that dealt with Oil and Petroleum Trading, Agriculture and Construction. In 2009 Mihail decided to move on to an American medical device company, heading the sales and marketing department outside the United States. That first exposure to the medical field paved the way to Mihail’s path as an entrepreneur as he genuinely believed that the medical device market needs products and services to fill a significant void.
In 2013, Mihail was approached by an American company called Global OrthoBiologic Inc. and he consequently took the role of Vice President. In the years to come, he vigorously transformed the company a Global Regenerative Group with 4 subsidiaries in Trade, Academy, Care and Finance, operating worldwide.
Mihail always believed that the most important quality an entrepreneur should possess is the ability to recognize the bigger picture, find where there is an opportunity to make someone’s life better and do it. Ultimately, it is the vision of the entrepreneur that dictates the future of the company. It is that exact vision that helped Mihail pursue a number of very successful investment opportunities primarily in early stage companies.
Making a social impact is as important to Mihail as developing new products and services. Mihail is currently participating in a variety of social enterprises such as a Medical Center for invasive regenerative therapies and a Foundation that helps people (mostly children) manage existing pathological conditions and diseases.
At the beginning of 2020, Mihail joined Orthoist clinic for advanced sports surgery, based in Turkey, as a business development manager.
During the 2020 the world is going through a major transition caused by a virus and made every single person to think about their loved ones and its own safety which caused this new phenomenon social distancing.
In a chaotic world, driven by hysteria and fear of pandemic events Mihail establish a brand “Medical Protection” to serve the world population and provide them with a quality products for a personal and medical protection.
Frederic Carbonnier is an international finance executive based in Geneva (Switzerland). Frederic has been a very successful advisor to families and entrepreneurs as a senior executive with some of the finest international banks. From 2010 to 2017, he held senior responsibilities for US key clients as CEO of UBP Investment Advisors (the entity of the UBP group focusing on US clients) and as senior banker with Pictet and Lombard Odier. From 2006 to 2010, Frederic was a Director with the international multi-family office Stonehage Flemming, advising ultra-high net worth families with their investment strategy, international tax and governance. Previously, Frederic was Finance Director of a New-York-based company in digital distribution of music (1997-2000). Frederic started his career as a corporate finance specialist for about 10 years with UBS in Geneva, Zurich and in New York. Frederic. He graduated with a Master of International Relations from the Graduate Institute of Geneva (Switzerland). He passed the US FINRA series 7 & 66 exams. He is fluent in 5 languages and has 3 children. Frederic plays piano and is an avid skier and tennis player.
Bio-Consulting International (CEO and Founder)
International Senior Consultant: Reimbursement, Regulatory and clinical affairs for the medtech industry, medical device industry, cosmetic and food ingredients, strategic consulting: Investors advisor, due diligence, fund raising
assistance, partnership, GMP QSR CEmark technical audits.
Expertise: Medical devices,Biomaterials, Orthobiologics, Spine industry, BioMedtechs, stem cells,
growth factors, biopolymers, food additives, combination products, cosmetics
ingredients, tissue engineering, regenerative medecine. Senior consultant for the VC community for 13 years:
strategicanalysis of future investments
BP analysis and discussions
Boardseats in 4 start-up companies
Chairman of a biomaterailcompany
shareholder and regulatory initiation (CE mark, 510k) in a
canadianregenerativetherapy for osteoarthrosistreatment
scouting in regenerativemedecine, stem cell and genetictherapylandscape,
networking withCEO's and VC's
European regulatory expert. Consulting customers:
WRIGHT CREMASCOLI ; DEPUY Int’l: LINK Germany and USA; HOWMEDICA USA ; MEDTRONIC
SOFAMOR DANEK ; FMS ; KASIOS ; ARTHREX ; EUROSURGICAL ; ISOTIS ; REGENERATION TECHNOLOGY ;
BIOBANK ; TUTOGEN ;KYPHON; BIOMET ; SPINE SOLUTIONS ; ABS ADVANCED BIOMATERIALS SAS ;
LINKSPINE (charité disc) ; STRYKER BIOTECH ; ORTHOVITA ; PRIM ; CTTC ; SPINENETWORK ; MEDTRONIC
DANEK ….LABORATOIRES GENEVRIER ; ANIKA THERAPEUTICS ; CERVITECH, PHUSIS, ANABIOR,
OLIGOMEDICS, CLARIANCE, FACET SOLUTIONS (now GLOBUS); LYTIX BIOPHARMA, REPLICATION
SIERA, APPLIED SPINE, VISCOGLIOSI BrothersLLCnew york, KEOPS, RANIER TECHNOLOGIES. ORTEQ.
SEVENTURE CAPITAL RISK. VIVOLUTION. MCRA (muskuloskeletal clinical and regulatory associate),
TORNIER. PARADIGM SPINE. DISC MOTION TECHNOLOGIES, ORTHOKNOW INGELHART, WARBURG
PINCUS, TEOXANE, TEROLAB, FILORGA COSMETICS, POLYMER TECHNOLOGIES food ingredients),
REVITACARE COSMETICS, , FACET Sol, ALPHATEC, NEVRO…
During the last fifteen years Jacques Allouf has been the Managing Director and Founder of Somerset Capital Group LLC, a company providing investment strategy to clients and advice in raising over $2 billion in funding for various projects. He was also Chairman of the Board of American Interactive Media, a publicly traded technology company financed by Pioneer and Hollinger International with more than 650 employees, Jacques Allouf has a bachelor’s degree from Paris, France. He also attended IDEC, a Film School in Paris, France and 2 years at the Faculte de Droit in Paris, France as well as 2 years at New York University, management and film production. Jacques was also the CEO/CFO of American Import LLC, a Car manufacturing advisory company securing several export agreements with Chinese car manufactures, the company had offices in Allentown PA and Shanghai, China.